drugset

drugset / Trial / NCT07634640

Hearts on Fire: Targeting Inflammation in Heart Failure With Preserved Ejection Fraction

NCT07634640 ↗

Phase 0 Recruiting 70 enrolled University of Florida American Heart Association · collab

NaSingle-groupOpen-labelOther

Summary

Subjects undergo a gadolinium-based CMR followed by an iron infusion and then a repeat CMR in 72 hours

Timeline

Start: 2023-11-03
Primary completion: 2027-05-31
Completion: 2027-05-31

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Ferumoxytol	Diagnostic / imaging agent	—	—

Indications